Conversation with The Cancer Letter UPMC’s Ferris: “Now there are more system-wide pressures to make a budget and to monitor quality” October 20, 2017Vol.43 No.39By Paul Goldberg
So you want to be a cancer center director…AACI sees nearly one-in -four turnover in 12 months among directors at top academic cancer centers October 20, 2017Vol.43 No.39By Paul Goldberg
Nine researchers receive the 2017 NIH Director’s New Innovator Award for cancer-related discoveries October 13, 2017Vol.43 No.38
Conversation with The Cancer Letter Rubin: FDA helped Merck figure out how to channel science into regulatory approval October 13, 2017Vol.43 No.38By Paul Goldberg
Conversation with The Cancer Letter Lemery: “We saw consistent evidence of the drug’s response in multiple tumor types” October 13, 2017Vol.43 No.38By Paul Goldberg
NIH announces immunotherapy consortium with 11 companies to support Cancer Moonshot goals October 13, 2017Vol.43 No.38By Matthew Bin Han Ong
FDA: the development of site-agnostic indications calls for development of sponsor-agnostic diagnostics October 13, 2017Vol.43 No.38By Paul Goldberg
